We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLAMW
12851
DELISTED
Slam Corp. warrant
SLAMW
$38K ﹤0.01%
91,526
-200
-0.2% -$93
BTCY
12852
CALL
DELISTED
Biotricity, Inc. Common Stock
BTCY
$38K ﹤0.01%
2,783
-1,134
-29% -$19.7K
ENG
12853
PUT
DELISTED
ENGlobal Corp
ENG
$38K ﹤0.01%
3,613
+1,450
+67% +$14.1K
KBNT
12854
CALL
DELISTED
Kubient, Inc. Common Stock
KBNT
$38K ﹤0.01%
22,200
-11,200
-34% -$24.4K
SPPI
12855
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$38K ﹤0.01%
29,800
-36,300
-55% -$33.4K
IPVIW
12856
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$38K ﹤0.01%
75,063
+63
+0.1% +$34
HIL
12857
CALL
DELISTED
Hill International, Inc. Common Stock
HIL
$38K ﹤0.01%
23,300
-11,900
-34% -$22.6K
NDACW
12858
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$38K ﹤0.01%
79,179
-82,518
-51% -$48K
FLACW
12859
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$38K ﹤0.01%
167,107
-9,192
-5% -$3.99K
AVAN.WS
12860
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$38K ﹤0.01%
146,588
-11,276
-7% -$4.07K
CLAS.WS
12861
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$38K ﹤0.01%
204,724
-23,401
-10% -$7.79K
AQST icon
12862
CALL
Aquestive Therapeutics
AQST
$494M
$37K ﹤0.01%
14,000
-41,000
-75% -$120K
EM
12863
DELISTED
Smart Share Global Ltd
EM
$37K ﹤0.01%
28,447
+645
+2% +$962
GALT icon
12864
CALL
Galectin Therapeutics
GALT
$348M
$37K ﹤0.01%
22,800
-55,100
-71% -$107K
PIM
12865
Franklin Master Intermediate Income Trust
PIM
$151M
$37K ﹤0.01%
10,471
-20,775
-66% -$75.4K
SOGP
12866
Sound Group
SOGP
$52.7M
$37K ﹤0.01%
+2,458
New +$36.5K
TRX icon
12867
TRX Gold Corp
TRX
$344M
$37K ﹤0.01%
119,428
+108,635
+1,007% +$40.1K
VANI icon
12868
PUT
Vivani Medical
VANI
$122M
$37K ﹤0.01%
8,633
-3,267
-27% -$13.7K
XFOR icon
12869
CALL
X4 Pharmaceuticals
XFOR
$460M
$37K ﹤0.01%
703
+56
+9% +$3.21K
TTOO
12870
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$37K ﹤0.01%
14
-11
-44% -$23.4K
FRTX
12871
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$37K ﹤0.01%
3,054
-692
-18% -$7.48K
PYR
12872
PUT
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$37K ﹤0.01%
14,700
-218,100
-94% -$503K
ZYNE
12873
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$37K ﹤0.01%
18,200
-4,400
-19% -$10.5K
LCI
12874
DELISTED
Lannett Company, Inc.
LCI
$37K ﹤0.01%
11,672
-11,815
-50% -$51.9K
EDTXW
12875
DELISTED
EdtechX Holdings Acquisition Corp. II Warrant
EDTXW
$37K ﹤0.01%
247,421
-15,189
-6% -$4.23K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.